Dermatology and Skin Diseases

Atopic dermatitis is a chronic inflammatory skin condition driven by a breakdown in the epithelial barrier, where mutations in the filaggrin gene allow allergens and microbes to penetrate skin that would otherwise keep them out. This barrier failure sets off a cascade of immune dysregulation, with signaling molecules like TSLP amplifying allergic inflammation and the skin microbiome—particularly overgrowth of Staphylococcus aureus—further destabilizing the immune environment and triggering the intense itch, or pruritus, that defines the disease. The development of dupilumab, a biologic that blocks key inflammatory pathways, has transformed treatment for severe cases, but researchers are still working to understand why some patients respond poorly and how early-life microbial exposures shape long-term disease risk. Clarifying the precise sequence of events between barrier dysfunction, immune activation, and microbial shifts remains one of the field's central unresolved problems.

Works

102,417

Total citations

1,455,526

Keywords

FilaggrinSkin MicrobiomeTSLPEczemaImmune DysregulationPruritus